Germany
Japan
United Kingdom
China
USD 428.00
In Stock
Research Areas
View as table Download
Goat Polyclonal Anti-CD45 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 1,260 aa to the C-terminus of human CD45 produced in E. coli. |
Goat Polyclonal Anti-CD19 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 510 aa to the C-terminus of human CD19 produced in E. coli. |
Rabbit Polyclonal ROCK1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human ROCK1 |
Rabbit polyclonal Neprilysin Antibody (C-term)
| Applications | FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This Neprilysin antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 506-534 amino acids from the C-terminal region of human Neprilysin. |
Rabbit Polyclonal C/EBP- beta (Thr235/188) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human C/EBP- beta around the phosphorylation site of Threonine 235/188 |
| Modifications | Phospho-specific |
Goat Polyclonal Antibody against WNT4
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-SNWLYLAKLSSVGS, from the internal region of the protein sequence according to NP_110388.2. |
Rabbit polyclonal antibody to WNT10A (wingless-type MMTV integration site family, member 10A)
| Applications | IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 47 and 271 of WNT10A (Uniprot ID#Q9GZT5) |
Rabbit polyclonal Estrogen Receptor-a (Ab-537) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Estrogen Receptor-a around the phosphorylation site of tyrosine 537 (P-L-YP-D-L). |
Rabbit polyclonal Estrogen Receptor-a (Tyr537) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human ER-a around the phosphorylation site of tyrosine 537 (P-L-YP-D-L). |
| Modifications | Phospho-specific |
Rabbit polyclonal anti-ROR2 antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from Internal of human ROR2. |
Rabbit polyclonal anti-FZD10 antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human FZD10. |
WNT2B Rabbit Polyclonal (Internal) Antibody
| Applications | IHC |
| Reactivities | Bat, Bovine, Hamster, Human, Monkey, Mouse, Rabbit, Rat, Gorilla, Dog, Pig, Horse, Gibbon |
| Conjugation | Unconjugated |
| Immunogen | WNT2B antibody was raised against synthetic 16 amino acid peptide from internal region of human WNT2B. Percent identity with other species by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Marmoset, Mouse, Rat, Bovine, Dog, Bat, Hamster, Panda, Horse, Rabbit, Pig (100%); Elephant (94%); Opossum, Platypus (88%). |
Rabbit Anti-Human TLR5 Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | TLR5 antibody was raised against synthetic peptide from human TLR5. |
Rabbit polyclonal CEBP Delta antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This affinity purified antibody was prepared from whole rabbit serum produced by repeated immunizations with a recombinant protein corresponding to the amino terminus of mouse C/EBP. |
Rat Anti-Human/Mouse CD45R (B220) Purified (100 ug)
| Applications | FC |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Rabbit Polyclonal CD19 Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human CD19 |
Rabbit Polyclonal CD19 (Tyr531) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human CD19 around the phosphorylation site of Tyrosine 531 |
| Modifications | Phospho-specific |
Goat Polyclonal Anti-CD19 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 510 aa to the C-terminus of human CD19 produced in E. coli. |
Goat Polyclonal Anti-CD45 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 1,260 aa to the C-terminus of human CD45 produced in E. coli. |
Goat Polyclonal Antibody against FZD7
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-RFYHRLSHSSKGET, from the C Terminus of the protein sequence according to NP_003498.1. |
Rabbit polyclonal anti-CEBPE antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human CEBPE. |
Rabbit polyclonal Estrogen Receptor-a (Ser102) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Estrogen Receptor-a around the phosphorylation site of serine 102 (L-N-SP-V-S). |
| Modifications | Phospho-specific |
Rabbit polyclonal anti-FZD4 antibody
| Applications | IF |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human FZD4. |
Rabbit polyclonal anti-MAPK10 antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human MAPK10. |
Rabbit polyclonal JNK1/2/3 (Thr183+Tyr185) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human JNK1/2/3 around the phosphorylation site of threonine183/tyrosine 185 (M-M-TP-P-YP-V-V). |
| Modifications | Phospho-specific |
Rabbit polyclonal anti-TCF4/12 antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human TCF4/12. |
Rabbit polyclonal anti-WNT1 antibody
| Applications | IHC |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from Internal of human WNT1. |
Rabbit polyclonal anti-FZD8 antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human FZD8 |
Rabbit polyclonal anti-FZD9 antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from N-terminal of human FZD9. |
Rabbit Polyclonal Integrin beta3 (Tyr773) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Integrin beta3 around the phosphorylation site of Tyrosine 773 |
| Modifications | Phospho-specific |
Rabbit Polyclonal Integrin beta3 (Tyr785) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Integrin beta3 around the phosphorylation site of Tyrosine 785 |
| Modifications | Phospho-specific |
Rabbit Polyclonal KIT (Tyr703) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human KIT around the phosphorylation site of Tyrosine 703 |
| Modifications | Phospho-specific |
Active filters
Reactivities
- Mouse
Availabilities
- In Stock
Filter by
Category
Target Symbol
- LGALS3 (36)
- ESR1 (25)
- NCAM1 (25)
- WNT3 (19)
- MME (18)
- DVL2 (14)
- ROR2 (13)
- ANAPC11 (12)
- TYRO3 (12)
- MAPK8 (11)
- MAPK9 (11)
- PDCD1 (11)
- ANAPC2 (7)
- RORA (7)
- ITGB3 (6)
- POSTN (6)
- PTK7 (6)
- CD19 (5)
- MAPK10 (5)
- PTPRC (5)
- CEBPD (4)
- FZD8 (4)
- KIT (4)
- CD2 (3)
- FZD3 (3)
- FZD4 (3)
- ROCK1 (3)
- ROCK2 (3)
- ROR1 (3)
- AGBL2 (2)
- AGBL3 (2)
- AGTPBP1 (2)
- ANAPC10 (2)
- ANAPC13 (2)
- ANPEP (2)
- CD22 (2)
- CEBPB (2)
- CRP (2)
- ESR2 (2)
- FZD10 (2)
- FZD2 (2)
- IL2RA (2)
- LEF1 (2)
- LRP5 (2)
- MS4A1 (2)
- TLR1 (2)
- TLR2 (2)
- TLR7 (2)
- TLR8 (2)
- TNF (2)
- TOLLIP (2)
- WNT10A (2)
- WNT2B (2)
- AGBL1 (1)
- AGBL5 (1)
- ANAPC5 (1)
- ARAF (1)
- BRAF (1)
- CASP1 (1)
- CD33 (1)
- CDC42SE2 (1)
- CR2 (1)
- CSRP1 (1)
- ELK3 (1)
- FZD1 (1)
- FZD5 (1)
- FZD6 (1)
- FZD7 (1)
- FZD9 (1)
- HSF1 (1)
- IK (1)
- IL1B (1)
- IL1R2 (1)
- IL1RL1 (1)
- IL3RA (1)
- INTS1 (1)
- IRS1 (1)
- ITGA2B (1)
- ITGAX (1)
- LRP6 (1)
- MAP2K2 (1)
- MAP2K4 (1)
- MAP3K13 (1)
- MAP3K5 (1)
- MAP4K1 (1)
- MAPK14 (1)
- PAK4 (1)
- PIK3CG (1)
- PRKCE (1)
- PTK2 (1)
- RPS6KA2 (1)
- SH3GL1 (1)
- SHC1 (1)
- SRC (1)
- STAT3 (1)
- STK11 (1)
- TCF4 (1)
- TLR5 (1)
- TLR6 (1)
- TMED1 (1)
Applications
Antibody Hosts
Isotypes
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
Assay Types
Assay Platforms
Families
- Druggable Genome (326)
- Transmembrane (175)
- ES Cell Differentiation/IPS (91)
- Protein Kinase (85)
- Secreted Protein (77)
- Transcription Factors (48)
- Nuclear Hormone Receptor (34)
- Protease (23)
- GPCR (14)
- Adult stem cells (9)
- Phosphatase (5)
- Embryonic stem cells (4)
- Stem cell - Pluripotency (4)
- Cancer stem cells (3)
- Stem cell relevant signaling - Wnt Signaling pathway (3)
- Induced pluripotent stem cells (1)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
Pathways
- Pathways in cancer (102)
- Wnt signaling pathway (100)
- Melanogenesis (69)
- Colorectal cancer (65)
- Basal cell carcinoma (64)
- Progesterone-mediated oocyte maturation (56)
- Hematopoietic cell lineage (52)
- Cell adhesion molecules (CAMs) (46)
- Focal adhesion (46)
- Toll-like receptor signaling pathway (46)
- MAPK signaling pathway (39)
- ErbB signaling pathway (36)
- Neurotrophin signaling pathway (35)
- Fc epsilon RI signaling pathway (34)
- Insulin signaling pathway (33)
- T cell receptor signaling pathway (33)
- Adipocytokine signaling pathway (32)
- NOD-like receptor signaling pathway (32)
- Type II diabetes mellitus (32)
- GnRH signaling pathway (31)
- Pancreatic cancer (31)
- Epithelial cell signaling in Helicobacter pylori infection (30)
- RIG-I-like receptor signaling pathway (30)
- Hedgehog signaling pathway (29)
- Prion diseases (27)
- Oocyte meiosis (25)
- Cell cycle (24)
- Ubiquitin mediated proteolysis (24)
- Alzheimer's disease (21)
- Regulation of actin cytoskeleton (21)
- Renin-angiotensin system (20)
- Notch signaling pathway (14)
- Acute myeloid leukemia (11)
- Chemokine signaling pathway (11)
- Cytokine-cytokine receptor interaction (11)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (10)
- B cell receptor signaling pathway (10)
- Dilated cardiomyopathy (10)
- Hypertrophic cardiomyopathy (HCM) (10)
- Leukocyte transendothelial migration (10)
- Primary immunodeficiency (10)
- Vascular smooth muscle contraction (10)
- Axon guidance (8)
- Endocytosis (8)
- Pathogenic Escherichia coli infection (8)
- TGF-beta signaling pathway (8)
- ECM-receptor interaction (7)
- Fc gamma R-mediated phagocytosis (7)
- Natural killer cell mediated cytotoxicity (7)
- Endometrial cancer (6)
- Prostate cancer (6)
- Amyotrophic lateral sclerosis (ALS) (5)
- Apoptosis (5)
- Chronic myeloid leukemia (5)
- Glioma (5)
- Jak-STAT signaling pathway (5)
- Renal cell carcinoma (5)
- VEGF signaling pathway (5)
- Adherens junction (4)
- Long-term potentiation (4)
- Melanoma (4)
- Non-small cell lung cancer (4)
- Thyroid cancer (4)
- mTOR signaling pathway (4)
- Bladder cancer (3)
- Graft-versus-host disease (3)
- Long-term depression (3)
- Small cell lung cancer (3)
- Tight junction (3)
- Type I diabetes mellitus (3)
- Allograft rejection (2)
- Asthma (2)
- Cytosolic DNA-sensing pathway (2)
- Gap junction (2)
- Glutathione metabolism (2)
- Metabolic pathways (2)
- Systemic lupus erythematosus (2)
- Complement and coagulation cascades (1)
- Inositol phosphate metabolism (1)
- Phosphatidylinositol signaling system (1)
- Vibrio cholerae infection (1)
- Viral myocarditis (1)